Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology

Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatia, Rohit, Srivastava, M. V. Padma, Khurana, Dheeraj, Pandit, Lekha, Mathew, Thomas, Gupta, Salil, Netravathi, M, Nair, Sruthi S., Singh, Gagandeep, Singhal, Bhim S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
View Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213028/
https://www.ncbi.nlm.nih.gov/pubmed/32419748
http://dx.doi.org/10.4103/0972-2327.282442
_version_ 1783531719504166912
author Bhatia, Rohit
Srivastava, M. V. Padma
Khurana, Dheeraj
Pandit, Lekha
Mathew, Thomas
Gupta, Salil
Netravathi, M
Nair, Sruthi S.
Singh, Gagandeep
Singhal, Bhim S.
author_facet Bhatia, Rohit
Srivastava, M. V. Padma
Khurana, Dheeraj
Pandit, Lekha
Mathew, Thomas
Gupta, Salil
Netravathi, M
Nair, Sruthi S.
Singh, Gagandeep
Singhal, Bhim S.
author_sort Bhatia, Rohit
collection PubMed
description Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during the current COVID-19 pandemic.
format Online
Article
Text
id pubmed-7213028
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-72130282020-05-15 Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology Bhatia, Rohit Srivastava, M. V. Padma Khurana, Dheeraj Pandit, Lekha Mathew, Thomas Gupta, Salil Netravathi, M Nair, Sruthi S. Singh, Gagandeep Singhal, Bhim S. Ann Indian Acad Neurol View Point Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during the current COVID-19 pandemic. Wolters Kluwer - Medknow 2020-04 2020-04-13 /pmc/articles/PMC7213028/ /pubmed/32419748 http://dx.doi.org/10.4103/0972-2327.282442 Text en Copyright: © 2006 - 2020 Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle View Point
Bhatia, Rohit
Srivastava, M. V. Padma
Khurana, Dheeraj
Pandit, Lekha
Mathew, Thomas
Gupta, Salil
Netravathi, M
Nair, Sruthi S.
Singh, Gagandeep
Singhal, Bhim S.
Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
title Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
title_full Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
title_fullStr Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
title_full_unstemmed Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
title_short Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
title_sort consensus statement on immune modulation in multiple sclerosis and related disorders during the covid-19 pandemic: expert group on behalf of the indian academy of neurology
topic View Point
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213028/
https://www.ncbi.nlm.nih.gov/pubmed/32419748
http://dx.doi.org/10.4103/0972-2327.282442
work_keys_str_mv AT bhatiarohit consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT srivastavamvpadma consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT khuranadheeraj consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT panditlekha consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT mathewthomas consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT guptasalil consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT netravathim consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT nairsruthis consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT singhgagandeep consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology
AT singhalbhims consensusstatementonimmunemodulationinmultiplesclerosisandrelateddisordersduringthecovid19pandemicexpertgrouponbehalfoftheindianacademyofneurology

Ejemplares similares